Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05062538 · ClinicalTrials.gov registry record
Cancer Patient Perspectives During COVID-19
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 89
- Enrollment target
NCT05062538: Completed study, sponsored by University of Colorado, Denver.
NCT05062538 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05062538 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 89 participants
- Enrollment target
Study Summary
A web-based survey will be emailed to all adult women diagnosed with invasive breast cancer or ductal carcinoma in situ who have been seen as surgical consultations within the last year (06/01/19-06/01/20).
Primary Outcome
Number of participants with changes implemented to breast cancer treatment during the COVID-19 pandemic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2020-08-24 |
| Est. Completion | 2024-07-15 |
What the finished NCT05062538 record still lists
NCT05062538 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 89 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05062538 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05062538 about?
NCT05062538 is a clinical study titled "Cancer Patient Perspectives During COVID-19". A web-based survey will be emailed to all adult women diagnosed with invasive breast cancer or ductal carcinoma in situ who have been seen as surgical consultations within the last year (06/01/19-06/01/20).
What is the current status of trial NCT05062538?
This trial is currently completed. The enrollment target is 89 participants. The study started on 2020-08-24. Estimated completion is 2024-07-15.
Who is sponsoring clinical trial NCT05062538?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI